Trial Profile
A Study Investigating the Prevalence and Characteristics of Dabigatran-Induced Esophagitis (DIE) in Patients who Underwent Radiofrequency Catheter Ablation for Atrial Fibrillation (AF)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Sep 2017
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Apixaban; Edoxaban; Rivaroxaban; Warfarin
- Indications Thromboembolism
- Focus Adverse reactions
- 29 Sep 2017 New trial record
- 30 Aug 2017 Results presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology.